Zhang Lei, Peng Kaiyun, Gao Aijun
Department of Medical Laboratory Technology, Medical College, Yangzhou Polytechnic College Yangzhou 225009, Jiangsu, PR China.
Clinical Laboratory, Yangzhou Hospital of TCM Yangzhou 225009, Jiangsu, PR China.
Am J Transl Res. 2024 Dec 15;16(12):7994-8007. doi: 10.62347/YVEE7827. eCollection 2024.
In vitro experiments were manipulated to investigate the effect of the (PICALM-interacting mitotic regulator gene) expression level on the malignant phenotype of liver cancer cells and their tumorigenesis ability in nude mice, and bioinformatics were used to analyze the clinical diagnostic and prognostic value in liver cancer.
After liver cancer-related data were obtained from the TCGA database and GTEx database, the differences in expression in liver cancer and normal liver tissue were compared using bioinformatics, and their correlation with the clinical pathological characteristics of liver cancer and the prognosis value were analyzed. A knockdown and overexpression model of was constructed using Huh7 cells. The effect of the expression level on the malignant phenotype of Huh7 cells was tested through CCK-8 and Transwell experiments. At the same time, animal knockdown and overexpression models were constructed to study the effect of the expression level on the tumorigenesis ability in nude mice.
Bioinformatics analysis showed that mRNA was significantly overexpressed in liver cancer tissue (<0.001). There were differences in T-staging (<0.001), pathological staging (=0.002), vascular infiltration (<0.001), histological grading (<0.001), and AFP levels (<0.001) between the high- and low-expression groups. A high expression of is associated with a poor prognosis, manifested as a significant decrease in the overall survival, disease-specific survival, and progression-free survival rates of patients ( values of 0.006, 0.014, and 0.002, respectively). In the overexpression model, the proliferation rate and invasion ability of Huh7 cells were significantly increased, and the tumorigenesis ability of nude mice was significantly enhanced. In the knockdown model, the opposite results were observed.
The gene is highly expressed in hepatocellular carcinoma, and increasing its expression level can significantly promote the malignant phenotype of liver cancer cells and their tumorigenesis ability in nude mice. Knocking down its expression level has the opposite effect. The expression level of is related to the pathological stages of liver cancer patients, and its elevated expression is a risk factor for poor prognosis. may become a new target for the clinical diagnosis, treatment, and prognosis evaluation of liver cancer.
通过体外实验研究(与PICALM相互作用的有丝分裂调节基因)表达水平对肝癌细胞恶性表型及其在裸鼠体内致瘤能力的影响,并运用生物信息学分析其在肝癌中的临床诊断及预后价值。
从TCGA数据库和GTEx数据库获取肝癌相关数据后,利用生物信息学比较肝癌组织和正常肝组织中该基因的表达差异,并分析其与肝癌临床病理特征及预后价值的相关性。采用Huh7细胞构建该基因的敲低和过表达模型。通过CCK-8和Transwell实验检测该基因表达水平对Huh7细胞恶性表型的影响。同时构建动物敲低和过表达模型,研究该基因表达水平对裸鼠致瘤能力的影响。
生物信息学分析显示,该基因mRNA在肝癌组织中显著高表达(<0.001)。高表达组和低表达组在T分期(<0.001)、病理分期(=0.002)、血管浸润(<0.001)、组织学分级(<0.001)和甲胎蛋白水平(<0.001)方面存在差异。该基因高表达与预后不良相关,表现为患者总生存、疾病特异性生存和无进展生存率显著降低(分别为0.006、0.014和0.002)。在该基因过表达模型中,Huh7细胞的增殖率和侵袭能力显著增加,裸鼠的致瘤能力显著增强。在敲低模型中,观察到相反的结果。
该基因在肝细胞癌中高表达,提高其表达水平可显著促进肝癌细胞的恶性表型及其在裸鼠体内的致瘤能力。敲低其表达水平则产生相反的效果。该基因的表达水平与肝癌患者的病理分期相关,其表达升高是预后不良的危险因素。该基因可能成为肝癌临床诊断、治疗及预后评估的新靶点。